The Journal of the American Academy of Orthopaedic Surgeons
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Fracture Risk in Overweight or Obese, Nondiabetic Patients.
Evangelia Constantine, Luke Enthoven, Riley Kahan, Emily M Pflug, Alexander Lauder
Published: 202510.5435/JAAOS-D-24-01505
Abstract
INTRODUCTION: Glucagon-like peptide-1 receptor agonists (GLP-1RA) are prescribed for glycemic control and weight reduction. Little is known regarding the impact of GLP-1RAs on bone health in patients without diabetes. METHODS: This retrospective case…
Preview only. Read the full abstract at the source